The World’s First AI Genomic-Based Skincare Line
Designed to Address Japanese and Asian Environmental Skin Aging
TOKYO, Dec. 09, 2025 — (Japanese corporate name: Genesis Healthcare Co.), Japan’s foremost company in genomics and AI-powered preventive health and therapeutics, today introduced ALUNAÉ, the inaugural skincare line rooted in genomics and created to combat environmental aging specific to Japanese and Asian skin types.
Introducing ALUNAÉ
Skincare for Environmental Aging, Shaped by Genetics
Leveraging Japan’s most extensive genomic population database, ALUNAÉ marks a new chapter in skincare. Its development utilizes AI-driven genomic intelligence to guide the selection, combination, and optimization of ingredients, targeting the quantifiable impacts of environmental aging such as UV radiation, pollution, humidity fluctuations, and oxidative stress.
AI × Genomics
Mapping the Impact of Ingredients on the Skin’s Deeper Biology
This methodology is backed by research featured in “A Score-Based Rapid Screening and Network Visualization Method Based on Bioactive Ingredient-Induced Variations in Skin Cell Gene Expression” (Scientia Pharmaceutica, November, 2025), which confirms the screening of bioactive ingredients according to their genetic influence.
A Legacy of Smart Balance
GA-6 (Geno Active-6)
These discoveries led to GA-6 (Geno Active-6), a blend of six bioactive elements selected for their connection to biological pathways associated with moisture, luminosity, and adaptation to environmental stressors.
ALUNAÉ was created under the guidance of Dr. Tadayoshi Miyashita, a preeminent authority in Japanese cosmetic science with over fifty years of experience. His expertise was instrumental in formulating GA-6 to pinpoint ingredients that shield Japanese and Asian skin from UV rays, dryness, airborne particles, and urban pollution.
“At A.D.A.M. Innovations, our mission is to enhance beauty through science that evolves as dynamically as our environment,” stated Michel Mommejat, President of A.D.A.M. Innovations. “ALUNAÉ propels cosmetic innovation forward with genomic intelligence, creating a path for products tailored to the genetic requirements of Japanese and Asian skin.”
Introducing the ALUNAÉ collection
ALUNAÉ officially launches today, December 9, 2025, available solely via GeneLife’s e-commerce platform. A selective retail rollout is scheduled for 2026.
The line debuts with two premier products: ALUNAÉ Treatment Cream (JPY 14,800) and ALUNAÉ Treatment Essence (JPY 14,800). These are designed to work in synergy as a comprehensive regimen against environmental aging.
In honor of the season, a limited-edition gift set containing both products will be available for JPY 29,600, providing a refined first experience with the ALUNAÉ collection.
For additional information, please visit:
About A.D.A.M. Innovations Co.
Established in Tokyo in 2004, A.D.A.M. Innovations Co. (Japanese corporate name: Genesis Healthcare Co.) is a trailblazer in genomics, artificial intelligence, and precision health solutions. The firm creates advanced technologies across consumer genetics, clinical diagnostics, and AI-powered R&D data platforms. To date, A.D.A.M. Innovations has performed over 2.8 million genetic tests and curates the largest R&D genomic database for the Japanese population.
About GeneLife
GeneLife is the consumer genomics brand under A.D.A.M. Innovations. It provides genetic testing directly to consumers via at-home kits and online sales channels. Commanding a 74% market share (source: Fuji Kimera), GeneLife is the industry leader, offering personalized health and wellness information to promote improved living and longevity.
ALUNAÉ and GeneLife are registered trademarks of A.D.A.M. Innovations Co.
Corporate contact:
Email: press@adam-innnovations.com
Media Relations:
Crocker Coulson
Email: Crocker.Coulson@aumadvisors.com
+1 (646) 652-7185
